OSCR

EMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond.

Overview

Authors: Kirill A. Arsentiev1, Abigail Fajardo2, Arseniy E. Yuzhalin1
  1. Research Center for Translational Medicine, Sirius University of Science and Technology, Sochi, Russia
  2. The University of Texas Health Science Center, Houston, TX, United States
Journal: Frontiers in oncology, volume 16, article 1771697
Dates: received 19 December 2025; accepted 16 March 2026; published online 1 April 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.3389/fonc.2026.1771697 · PMID 41994657 · PMCID PMC13078994 · OpenAlex W7147007292
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: other condition (population), cellular / molecular (subfield)
Methods: Smoothing, state filtering, decompositions
Keywords: cancer, CNS tumors, EMILIN-1, extracellular matrix, glioblastoma multiforme, tumor microenvironment, tumor, vasculature
Topic: Cell Adhesion Molecules Research (Immunology and Allergy, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 73 references in the paper

Abstract

Elastin Microfibril Interface Located Protein 1 (EMILIN-1) is a multifunctional extracellular glycoprotein, primarily involved in maintaining tissue homeostasis. Known for regulation of elastogenesis and vascular stability, EMILIN-1 has emerged as a key modulator of multiple biological processes, including cell adhesion, migration, and proliferation. Recent experimental data highlight the importance of EMILIN-1 in cancer biology, especially in malignant tumors of the nervous system, where EMILIN-1’s regulatory functions influence tumor progression and metastatic potential. Specifically, EMILIN-1 can exert tumor-suppressive effects by modulating cell signaling pathways of tumor cells and EMILIN-1 can also alter the immune response and promote progression of brain tumors. This review article provides a comprehensive analysis of the recently discovered mechanisms through which EMILIN-1 promotes tumor progression in the nervous system and other sites.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added National Institutes of Health

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 3 authors, 8 keywords, 73 references.

Cite

This paper

Arsentiev, K. A., Fajardo, A., & Yuzhalin, A. E. (2026). EMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond. Frontiers in oncology, 16, 1771697. https://doi.org/10.3389/fonc.2026.1771697

BibTeX

@article{arsentiev2026emilin,
author = {Arsentiev, Kirill A. and Fajardo, Abigail and Yuzhalin, Arseniy E.},
title = {{EMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond}},
journal = {Frontiers in oncology},
year = {2026},
month = apr,
volume = {16},
pages = {1771697},
publisher = {Frontiers Media SA},
issn = {2234-943X},
doi = {10.3389/fonc.2026.1771697},
url = {https://doi.org/10.3389/fonc.2026.1771697},
pmid = {41994657},
pmcid = {PMC13078994}
}

RIS

TY - JOUR
AU - Arsentiev, Kirill A.
AU - Fajardo, Abigail
AU - Yuzhalin, Arseniy E.
TI - EMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond
T2 - Frontiers in oncology
J2 - Front Oncol
PY - 2026
DA - 2026/04/01
VL - 16
SP - 1771697
SN - 2234-943X
PB - Frontiers Media SA
DO - 10.3389/fonc.2026.1771697
UR - https://doi.org/10.3389/fonc.2026.1771697
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fonc.2026.1771697",
"type": "article-journal",
"title": "EMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond",
"container-title": "Frontiers in oncology",
"author": [
{
"family": "Arsentiev",
"given": "Kirill A."
},
{
"family": "Fajardo",
"given": "Abigail"
},
{
"family": "Yuzhalin",
"given": "Arseniy E."
}
],
"container-title-short": "Front Oncol",
"volume": "16",
"page": "1771697",
"DOI": "10.3389/fonc.2026.1771697",
"PMID": "41994657",
"PMCID": "PMC13078994",
"ISSN": "2234-943X",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fonc.2026.1771697",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41588-026-02709-5
PLCG2 downregulation impairs synaptic function and increases Alzheimer's disease hallmarks in neuronal cultures.
Journal: Nature genetics
In common: portal.brain-map.org/atlases-and-data/rnaseq, cellular / molecular
[2] doi:10.3390/cimb48070691
Astrocyte Subtype-Specific Expression of the Sodium-Coupled Citrate Transporter <i>SLC13A5</i> and Citrate Metabolism Genes Across Alzheimer's Disease Pseudoprogression: A Single-Nucleus RNA Sequencing Analysis of the Human Middle Temporal Gyrus.
Journal: Current issues in molecular biology
In common: portal.brain-map.org/atlases-and-data/rnaseq, cellular / molecular
[3] doi:10.1186/s13059-026-04177-w [code]
Genomic sequence evolution underlying human neocortical interareal diversification.
Journal: Genome biology
In common: portal.brain-map.org/atlases-and-data/rnaseq, cellular / molecular
[4] doi:10.1186/s12929-026-01257-8
Distinct and combined interferon-ɑ/β-receptor-1 loss in neurons and astrocytes disrupt brain energy metabolism and drive Parkinsonian dementia.
Journal: Journal of biomedical science
In common: portal.brain-map.org/atlases-and-data/rnaseq, cellular / molecular
[5] doi:10.1038/s41467-026-73036-w [code]
Single-nucleus analysis reveals human-specific oligodendrocyte polarization and conserved neuronal responses after severe traumatic brain injury.
Journal: Nature communications
In common: portal.brain-map.org/atlases-and-data/rnaseq, cellular / molecular
[6] doi:10.1523/jneurosci.0019-26.2026 [code]
Endothelial <i>Adgrl2</i> Expression and Alternative Splicing Controls the Cerebrovasculature.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
In common: portal.brain-map.org/atlases-and-data/rnaseq, cellular / molecular
[7] doi:10.1186/s13041-026-01300-7
Hippocampal transcriptome profiling in a 22q11.2 deletion syndrome mouse model: comparison with human schizophrenia.
Journal: Molecular brain
In common: portal.brain-map.org/atlases-and-data/rnaseq, cellular / molecular
[8] doi:10.1038/s41467-026-75424-8
Major urinary protein 1 modulates neuronal excitability in the medial prefrontal cortex in a male mouse model of affective empathy.
Journal: Nature communications
In common: portal.brain-map.org/atlases-and-data/rnaseq
[9] doi:10.3390/ijms27156671
Inflamed Yet Immune-Evasive? A Transcriptomic Meta-Analysis Identifies Conserved Inflammatory, Developmental, and Neuronal Signatures Associated with Polyploid Giant Cancer Cells.
Journal: International journal of molecular sciences
In common: other condition, cellular / molecular, 1 reference
[10] doi:10.1038/s41419-026-08807-w [code]
Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis.
Journal: Cell death & disease
In common: other condition, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.